scholarly article | Q13442814 |
P356 | DOI | 10.1002/MDS.22838 |
P698 | PubMed publication ID | 20175185 |
P50 | author | Joaquim Ferreira | Q55232786 |
Elan D Louis | Q66933976 | ||
P2860 | cites work | Prevalence of essential tremor in Singapore: a study on three races in an Asian country | Q31170891 |
Neurological disorders in Nigerian Africans: a community-based study | Q33169019 | ||
Clinical practice. Essential tremor | Q34375183 | ||
Prevalence of movement disorders in men and women aged 50-89 years (Bruneck Study cohort): a population-based study | Q34468810 | ||
The emerging neuropathology of essential tremor | Q36999841 | ||
Neurological disorders in the elderly at home | Q37042676 | ||
Emergence of Parkinson's disease in essential tremor: a study of the clinical correlates in 53 patients | Q37195599 | ||
Environmental epidemiology of essential tremor | Q37196824 | ||
Prevalence of essential tremor in a multiethnic, community-based study in northern Manhattan, New York, N.Y. | Q37348022 | ||
Essential tremor might be less frequent than Parkinson's disease in North Israel Arab villages | Q37390127 | ||
Prevalence study of neurologic disorders in Kelibia (Tunisia). | Q38883354 | ||
The prevalence of essential tremor in rural northern Tanzania. | Q38976953 | ||
The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. | Q39532453 | ||
Essential tremor: an overdiagnosed condition? | Q39558844 | ||
Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain | Q39643547 | ||
Prevalence of essential tremor in three elderly populations of central Spain | Q39645940 | ||
A community survey of neurological disorders in Saudi Arabia: the Thugbah study | Q40796260 | ||
How common is the most common adult movement disorder? estimates of the prevalence of essential tremor throughout the world | Q41695134 | ||
Prevalence of essential tremor. Results from the Copiah County study | Q43810681 | ||
Prevalence of essential tremor: a door-to-door survey in Terrasini, Sicily. Sicilian Neuro-Epidemiologic Study Group. | Q44064307 | ||
Essential tremor in Papua, New Guinea | Q44985987 | ||
Differences in the prevalence of essential tremor among elderly African Americans, whites, and Hispanics in northern Manhattan, NY. | Q46517043 | ||
Evidence of increased odds of essential tremor in Parkinson's disease | Q46668594 | ||
Risk of incident Parkinson's disease and parkinsonism in essential tremor: a population based study | Q46970507 | ||
Prevalence of restless legs syndrome in a rural community in Japan. | Q48420020 | ||
Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. | Q49102378 | ||
Clinical update: diagnosis and treatment of essential tremor. | Q50276937 | ||
Prevalence of essential tremor in the territory of Lake Trasimeno, Italy: results of a population-based study. | Q50277457 | ||
Study of possible factors associated with age of onset in essential tremor. | Q50277992 | ||
Common misdiagnosis of a common neurological disorder: how are we misdiagnosing essential tremor? | Q50278163 | ||
Incidence of essential tremor in three elderly populations of central Spain. | Q50280077 | ||
Prevalence of essential tremor: door-to-door neurologic exams in Mersin Province, Turkey. | Q50284085 | ||
How normal is 'normal'? Mild tremor in a multiethnic cohort of normal subjects. | Q50905727 | ||
The Kinmen Neurological Disorders Survey (KINDS): a study of a Chinese population. | Q50970120 | ||
Does a screening questionnaire for essential tremor agree with the physician's examination? | Q51994288 | ||
Prevalence of essential tremor: a door-to-door survey in Sile, Istanbul, Turkey. | Q53125038 | ||
Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT Study. | Q53269982 | ||
Rest tremor in patients with essential tremor: prevalence, clinical correlates, and electrophysiologic characteristics. | Q53919266 | ||
Essential tremor in childhood: a series of nineteen cases. | Q55035574 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | essential tremor | Q693519 |
P304 | page(s) | 534-541 | |
P577 | publication date | 2010-02-19 | |
P1433 | published in | Movement Disorders | Q1486418 |
P1476 | title | How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor | |
P478 | volume | 25 |
Q26849958 | 'Essential tremor' or 'the essential tremors': is this one disease or a family of diseases? |
Q36812559 | 'When did my tremor start?': can essential tremor patients pinpoint their disease onset? |
Q37584204 | A Comparison Study of Cognitive and Neuropsychiatric Features of Essential Tremor and Parkinson's Disease |
Q93062230 | A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial of CX-8998, a Selective Modulator of the T-Type Calcium Channel in Inadequately Treated Moderate to Severe Essential Tremor: T-CALM Study Design and Methodology for Efficacy Endpoint and |
Q64786600 | A Quantitative Study of Empty Baskets in Essential Tremor and Other Motor Neurodegenerative Diseases |
Q92895083 | A case with essential tremor refractory to medication successfully treated with deep brain stimulation |
Q50262280 | A clinical test for the alcohol sensitivity of essential tremor. |
Q36347948 | A computerized tablet system for evaluating treatment of essential tremor by magnetic resonance guided focused ultrasound |
Q33708605 | A data mining approach using cortical thickness for diagnosis and characterization of essential tremor |
Q46135634 | A new paradigm for the management of essential vocal tremor with botulinum toxin |
Q35255502 | A patient with tremor, part 2: from diagnosis to treatment |
Q34555972 | Abnormal climbing fibre-Purkinje cell synaptic connections in the essential tremor cerebellum |
Q57471879 | Absence of Mutation Enrichment for Genes Phylogenetically Conserved in the Olivocerebellar Motor Circuitry in a Cohort of Canadian Essential Tremor Cases |
Q33575957 | Action Tremor Asymmetry Profile Does Not Aggregate in Families with Essential Tremor |
Q42370279 | Activity recognition with wearable sensors on loose clothing |
Q30574622 | Age of onset: can we rely on essential tremor patients to report this? Data from a prospective, longitudinal study |
Q24187196 | Alprazolam for essential tremor |
Q24201430 | Alprazolam for essential tremor |
Q64785505 | Alternating Thalamic Deep Brain Stimulation for Essential Tremor: A Trial to Reduce Habituation |
Q47570664 | Analysis of 3D spatial trajectories in Parkinsonian, essential and physiological tremors |
Q44032339 | Analysis of Lingo1 variant in sporadic and familial essential tremor among Asians |
Q37484363 | Approach to a tremor patient |
Q38413113 | Are patients with limb and head tremor a clinically distinct subtype of essential tremor? |
Q38628125 | Assessment of Three New Loci from Genome-wide Association Study in Essential Tremor in Chinese population. |
Q35123605 | Association between essential tremor and other neurodegenerative diseases: what is the epidemiological evidence? |
Q40848522 | Atrophy of the Cerebellar Vermis in Essential Tremor: Segmental Volumetric MRI Analysis |
Q48806623 | Audio-vestibular evaluation in patients with essential tremor. |
Q98290450 | Auditory and Olfactory Deficits in Essential Tremor - Review of the Current Evidence |
Q40489773 | Autonomic dysfunction in patients with essential tremor |
Q55362711 | Beta-carboline alkaloids and essential tremor: exploring the environmental determinants of one of the most prevalent neurological diseases. |
Q89963890 | Bilateral Posterior Subthalamic Area Deep Brain Stimulation for Essential Tremor: A Case Series |
Q48309265 | Bilateral thalamic deep brain stimulation for essential tremor in elderly patients. |
Q89485158 | Blood Harmane (1-Methyl-9H-Pyrido[3,4-b]indole) and Mercury in Essential Tremor: A Population-Based, Environmental Epidemiology Study in the Faroe Islands |
Q36565922 | Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentration in essential tremor cases in Spain |
Q34032624 | Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor: repeat observation in cases and controls in New York |
Q34024964 | Blood harmane, blood lead, and severity of hand tremor: evidence of additive effects |
Q50239228 | Botulinum Toxin Type A Injections as Monotherapy for Upper Limb Essential Tremor Using Kinematics. |
Q90369303 | Botulinum Toxin for the Treatment of Hand Tremor |
Q30528616 | Botulinum toxin as treatment for focal dystonia: a systematic review of the pharmaco-therapeutic and pharmaco-economic value |
Q50119361 | Brain Focused Ultrasound: what's the 'FUS' all about? A review of current and emerging neurological applications. |
Q99589427 | Candidate variants in TUB are associated with familial tremor |
Q30827654 | Cerebellar Atrophy in Cortical Myoclonic Tremor and Not in Hereditary Essential Tremor-a Voxel-Based Morphometry Study |
Q39303757 | Cerebellar Pathology in Early Onset and Late Onset Essential Tremor |
Q38863768 | Cerebellar Pathology in Familial vs. Sporadic Essential Tremor |
Q48829597 | Cerebellar dysfunction in essential tremor. |
Q40059778 | Cerebellar pathology in childhood-onset vs. adult-onset essential tremor. |
Q52684580 | Climbing fiber-Purkinje cell synaptic pathology across essential tremor subtypes. |
Q90043322 | Clinical correlates of abnormal subcortical volumes in Essential Tremor |
Q38998616 | Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective |
Q46407591 | Cognitive load results in motor overflow in essential tremor |
Q64253082 | Combined Visualization of Nigrosome-1 and Neuromelanin in the Substantia Nigra Using 3T MRI for the Differential Diagnosis of Essential Tremor and Parkinson's Disease |
Q64929400 | Combined accelerometer and genetic analysis to differentiate essential tremor from Parkinson's disease. |
Q50019392 | Comparative Burden of Subclinical Tremor in a Cohort of Normal Individuals Stratified by Familial Risk for Essential Tremor. |
Q60920295 | Comparing deep brain stimulation in the ventral intermediate nucleus versus the posterior subthalamic area in essential tremor patients |
Q44660700 | Computational modeling to improve treatments for essential tremor |
Q45074461 | Consensus Statement on the classification of tremors, from the task force on tremor of the International Parkinson and Movement Disorder Society |
Q33453790 | Continuous Monitoring of Essential Tremor Using a Portable System Based on Smartwatch |
Q61804294 | Controlling a motorized orthosis to follow elbow volitional movement: tests with individuals with pathological tremor |
Q40405241 | Correlates Between Force and Postural Tremor in Older Individuals with Essential Tremor. |
Q91958388 | Cost-minimisation model of magnetic resonance-guided focussed ultrasound therapy compared to unilateral deep brain stimulation for essential tremor treatment in Japan |
Q54959280 | Could Wearable and Mobile Technology Improve the Management of Essential Tremor? |
Q42371224 | Current and emerging brain applications of MR-guided focused ultrasound |
Q92311854 | DNA methylome study of human cerebellar tissues identified genes and pathways possibly involved in essential tremor |
Q48028469 | De Sedibus et Causis Morborum: is Essential Tremor a Primary Disease of the Cerebellum? |
Q47939590 | Deep Brain Stimulation for Essential Tremor: A Comparison of Targets. |
Q36391409 | Deep Brain Stimulation: Expanding Applications |
Q89962352 | Deep brain stimulation in essential tremor: targets, technology, and a comprehensive review of clinical outcomes |
Q87984340 | Deep brain stimulation in uncommon tremor disorders: indications, targets, and programming |
Q30372874 | Deep brain stimulation of the posterior subthalamic area and the thalamus in patients with essential tremor: study protocol for a randomized controlled pilot trial. |
Q34029544 | Defective dentate nucleus GABA receptors in essential tremor |
Q64063993 | Deficits in tapping accuracy and variability in tremor patients |
Q35994912 | Defining the Treatment Gap: What Essential Tremor Patients Want That They Are Not Getting |
Q64211498 | Demoralization in essential tremor: prevalence, clinical correlates, and dissociation from tremor severity |
Q41691324 | Depression and social phobia in essential tremor and Parkinson's disease |
Q91782887 | Design of a lightweight passive orthosis for tremor suppression |
Q52568192 | Development of Harmaline-induced Tremor in a Swine Model. |
Q55445844 | Diffusion MRI tractography for improved transcranial MRI-guided focused ultrasound thalamotomy targeting for essential tremor. |
Q46031341 | Diffusion tractography imaging-guided frameless linear accelerator stereotactic radiosurgical thalamotomy for tremor: case report. |
Q36331828 | Distinguishing essential tremor from Parkinson's disease: bedside tests and laboratory evaluations |
Q42366255 | Does non-invasive brain stimulation reduce essential tremor? A systematic review and meta-analysis |
Q50245589 | Dynamic decomposition of motion in essential and parkinsonian tremor. |
Q97436897 | Dysfunction of parvalbumin neurons in the cerebellar nuclei produces an action tremor |
Q50242103 | Early- and late-onset essential tremor patients represent clinically distinct subgroups. |
Q92583320 | Essential Tremor Is a Useful Concept? No |
Q36603305 | Essential Tremor Prevalence is Low in the Druze Population in Northern Israel |
Q91741309 | Essential Tremor as a "Waste Basket" Diagnosis: Diagnosing Essential Tremor Remains a Challenge |
Q92615803 | Essential Tremor is not Only a Movement Disorder; Its Relationship with Sleep and Anxiety |
Q33788649 | Essential Tremor: A Common Disorder of Purkinje Neurons? |
Q89853086 | Essential tremor |
Q88878748 | Essential tremor and depression |
Q50244545 | Essential tremor and senile varieties of action tremor an evolving ART. |
Q42397398 | Essential tremor in 'The tremulous hand of Worcester': additional comments |
Q40431266 | Essential tremor is associated with disruption of functional connectivity in the ventral intermediate Nucleus--Motor Cortex--Cerebellum circuit |
Q92784162 | Essential tremor pathology: neurodegeneration and reorganization of neuronal connections |
Q40107157 | Essential tremor then and now: How views of the most common tremor diathesis have changed over time |
Q36795766 | Essential tremor with ubiquitinated intranuclear inclusions and cerebellar degeneration |
Q37864533 | Essential tremor--a neurodegenerative disorder associated with cognitive defects? |
Q91449034 | Essential tremor-plus: a controversial new concept |
Q45809823 | Essential tremor: a unique diagnostic code in ICD-10-CM. |
Q34007462 | Essential tremor: from bedside to bench and back to bedside |
Q37968031 | Essential tremor: phenotypes |
Q33855255 | Estimating annual rate of decline: prospective, longitudinal data on arm tremor severity in two groups of essential tremor cases |
Q64275144 | Etiologic links between environmental and lifestyle factors and Essential tremor |
Q36152927 | Exome sequencing identifies FUS mutations as a cause of essential tremor |
Q37314162 | FUS-linked essential tremor associated with motor dysfunction in Drosophila |
Q36608484 | Familial Aggregation and Co-Aggregation of Essential Tremor and Parkinson's Disease |
Q37620990 | Familial Aggregation of the Cerebellar Signs in Familial Essential Tremor |
Q35103272 | Frailty in elderly persons with essential tremor: a population-based study (NEDICES). |
Q33831377 | From neurons to neuron neighborhoods: the rewiring of the cerebellar cortex in essential tremor |
Q93075453 | Fully automated leg tracking of Drosophila neurodegeneration models reveals distinct conserved movement signatures |
Q35629189 | Functional correlates of gait and balance difficulty in essential tremor: balance confidence, near misses and falls |
Q38685853 | Functional lesional neurosurgery for tremor-a protocol for a systematic review and meta-analysis |
Q37320149 | Gait variability magnitude but not structure is altered in essential tremor |
Q52614420 | Genetic Testing Preferences of Individuals in Families with Essential Tremor. |
Q35371392 | Genetic analysis of FMR1 repeat expansion in essential tremor |
Q39794819 | Genetic analysis of PITX3 variants in patients with essential tremor. |
Q36067824 | Genetic analysis of ten common degenerative hereditary ataxia loci in patients with essential tremor |
Q36888348 | Genetic analysis of the FUS/TLS gene in essential tremor |
Q37739868 | Genome-wide association study in essential tremor identifies three new loci |
Q64109101 | Genome-wide estimates of heritability and genetic correlations in essential tremor |
Q92100064 | Graph theory analysis of resting-state functional magnetic resonance imaging in essential tremor |
Q27309639 | Hcn1 is a tremorgenic genetic component in a rat model of essential tremor |
Q26801534 | Headache and Tremor: Co-occurrences and Possible Associations |
Q40089743 | Heterotopic Purkinje Cells: a Comparative Postmortem Study of Essential Tremor and Spinocerebellar Ataxias 1, 2, 3, and 6. |
Q44171906 | High width variability during spiral drawing: further evidence of cerebellar dysfunction in essential tremor |
Q30844973 | How many people in the USA have essential tremor? Deriving a population estimate based on epidemiological data |
Q21129430 | How to tackle tremor - systematic review of the literature and diagnostic work-up |
Q64054215 | IL1B polymorphism is associated with essential tremor in Chinese population |
Q35881822 | Impact of advancing age on post-operative complications of deep brain stimulation surgery for essential tremor |
Q35879615 | Impact of an Interdisciplinary Deep Brain Stimulation Screening Model on Post-Surgical Complications in Essential Tremor Patients |
Q50078056 | In Vivo Dentate Nucleus Gamma-aminobutyric Acid Concentration in Essential Tremor vs. Controls. |
Q34039911 | Increased LINGO1 in the cerebellum of essential tremor patients |
Q33805952 | Increased Odds of Melanoma: Parkinson's Disease, Essential Tremor, Dystonia versus Controls |
Q35815619 | Increased number of Purkinje cell dendritic swellings in essential tremor |
Q47838683 | Inferior Olivary nucleus degeneration does not lessen tremor in essential tremor |
Q36951657 | Investigating the role of FUS exonic variants in essential tremor |
Q50253334 | Investigation of the prevalence of essential tremor in individuals aged 18-60 in Erzurum. |
Q48942306 | Is essential tremor a Purkinjopathy? The role of the cerebellar cortex in its pathogenesis. |
Q42373417 | Is there a Premotor Phase of Essential Tremor? |
Q89520633 | Isolated Voice Tremor: A Clinical Variant of Essential Tremor or a Distinct Clinical Phenotype? |
Q27687018 | It is time to remove the 'benign' from the essential tremor label |
Q36640329 | Key issues in essential tremor genetics research: Where are we now and how can we move forward? |
Q49450694 | Knowledge about Essential Tremor: A Study of Essential Tremor Families. |
Q30244228 | Knowledge gaps and research recommendations for essential tremor |
Q64244853 | Lack of association between methylenetetrahydrofolate reductase gene variants & essential tremor in Han Chinese |
Q34036195 | Lingo-1 expression is increased in essential tremor cerebellum and is present in the basket cell pinceau |
Q31029808 | Linking Essential Tremor to the Cerebellum-Neuroimaging Evidence. |
Q38540998 | Linking Essential Tremor to the Cerebellum: Neuropathological Evidence |
Q89146173 | Long Trace Eyeblink Conditioning Is Largely Preserved in Essential Tremor |
Q92583859 | Long-term Thalamic Deep Brain Stimulation for Essential Tremor: Clinical Outcome and Stimulation Parameters |
Q34541604 | Macroautophagy abnormality in essential tremor |
Q61635298 | Magnetic Resonance-Guided Focused Ultrasound Neurosurgery for Essential Tremor: A Health Technology Assessment |
Q35013955 | Medication non-adherence in essential tremor |
Q38084595 | Methodological issues in clinical drug development for essential tremor |
Q37882599 | Milestones in tremor research |
Q28118169 | Missense mutations in TENM4, a regulator of axon guidance and central myelination, cause essential tremor |
Q34792986 | Mitochondrial serine protease HTRA2 p.G399S in a kindred with essential tremor and Parkinson disease |
Q50244492 | Motor network disruption in essential tremor: a functional and effective connectivity study. |
Q49922845 | Movement Disorders and Deep Brain Stimulation in the Middle East. |
Q38164872 | Movement disorders in childhood |
Q47600101 | Movement disorders: New hope for medically-refractory essential tremor? |
Q37627534 | Mutation Analysis of HTRA2 Gene in Chinese Familial Essential Tremor and Familial Parkinson's Disease. |
Q91997298 | Need for mechanically and ergonomically enhanced tremor-suppression orthoses for the upper limb: a systematic review |
Q35999520 | Neurofilament protein levels: quantitative analysis in essential tremor cerebellar cortex |
Q34431116 | Neuroimaging essentials in essential tremor: a systematic review |
Q30830361 | Neuroimaging studies of essential tremor: how well do these studies support/refute the neurodegenerative hypothesis? |
Q44170917 | New hope for severe essential tremor? |
Q38036239 | New horizons in the pathogenesis, assessment and management of movement disorders. |
Q90747467 | No rare deleterious variants from STK32B, PPARGC1A, and CTNNA3 are associated with essential tremor |
Q34242094 | Older age relates to worsening of fine motor skills: a population-based study of middle-aged and elderly persons |
Q92710498 | Oral propranolol for treatment of the subgroups of essential tremor: a systematic review and meta-analysis protocol |
Q58598885 | Outcomes from stereotactic surgery for essential tremor |
Q90329679 | PSA and VIM DBS efficiency in essential tremor depends on distance to the dentatorubrothalamic tract |
Q48122172 | Parkinson's disease with and without preceding essential tremor-similar phenotypes: a pilot study |
Q91246266 | Phenotypic Variability of Essential Tremor Based on the Age at Onset |
Q30539686 | Postural and Intention Tremors: A Detailed Clinical Study of Essential Tremor vs. Parkinson's Disease |
Q24203614 | Pregabalin for essential tremor |
Q38986127 | Pregabalin for essential tremor. |
Q38970463 | Prehension Kinematics, Grasping Forces, and Independent Finger Control in Mildly Affected Patients with Essential Tremor |
Q34903545 | Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: a cross-sectional survey. |
Q92481317 | Prevalence of Essential Tremor in the Faroe Islands: A Population-Based Study |
Q37189787 | Prevalence of Essential Tremor on Arosa Island, Spain: a Community-based, Door-to-Door Survey |
Q34619648 | Prevalence of essential tremor in Araihazar, Bangladesh: a population-based study |
Q38217353 | Prevalence of essential tremor in an idiopathic Parkinson's disease patient population. |
Q38782247 | Probabilistic mapping of deep brain stimulation effects in essential tremor |
Q53438502 | Probable REM-Sleep Behavior Disorder and Dysautonomic Symptoms in Essential Tremor. |
Q90463546 | Profiles of Normal Cognition in Essential Tremor |
Q99630643 | Prospective Home-use Study on Non-invasive Neuromodulation Therapy for Essential Tremor |
Q47106661 | Psychological Suffering in Essential Tremor: A Study of Patients and Those Who Are Close to Them |
Q36823679 | Public Knowledge and Attitude toward Essential Tremor: A Questionnaire Survey |
Q37200329 | Purkinje cell axonal anatomy: quantifying morphometric changes in essential tremor versus control brains |
Q36665007 | Purkinje cell loss in essential tremor: Random sampling quantification and nearest neighbor analysis |
Q48538042 | Quality of life following DBS in the caudal zona incerta in patients with essential tremor. |
Q37315829 | Quantification of cerebellar hemispheric purkinje cell linear density: 32 ET cases versus 16 controls |
Q90418663 | Quantitative Assessment of Head Tremor in Patients with Essential Tremor and Cervical Dystonia by Using Inertial Sensors |
Q36252301 | Quantitative Assessment of Parkinsonian Tremor Based on an Inertial Measurement Unit |
Q34899054 | Reduced body mass index in essential tremor: a study of 382 cases and 392 matched controls |
Q47842548 | Relations between psychological avoidance, symptom severity and embarrassment in essential tremor |
Q34279991 | Relationship between blood harmane and harmine concentrations in familial essential tremor, sporadic essential tremor and controls |
Q48913317 | Resting State fMRI Demonstrates a Disturbance of the Cerebello-Cortical Circuit in Essential Tremor. |
Q55709400 | Resting-state fMRI study on drug-naive patients of essential tremor with and without head tremor. |
Q44976807 | Revisiting the relationship between essential tremor and Parkinson's disease |
Q34368122 | Riluzole Ameliorates Harmaline-induced Tremor in Rat. |
Q92824054 | Role of cerebellar GABAergic dysfunctions in the origins of essential tremor |
Q36302123 | SCN4A pore mutation pathogenetically contributes to autosomal dominant essential tremor and may increase susceptibility to epilepsy |
Q33805958 | Screening for and Estimating the Prevalence of Essential Tremor: A Random-Digit Dialing-Based Study in the New York Metropolitan Area |
Q92407455 | Sex differences in movement disorders |
Q36610164 | Sleep in essential tremor: a comparison with normal controls and Parkinson's disease patients |
Q38668648 | Structural connectivity differences in essential tremor with and without resting tremor |
Q48217638 | Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease |
Q30277621 | Surgery for Dystonia and Tremor |
Q38084596 | Sustained Medication Reduction Following Unilateral VIM Thalamic Stimulation for Essential Tremor |
Q58762277 | Systematic analysis of genetic variants in patients with essential tremor |
Q35534253 | TREM2 R47H variant and risk of essential tremor: a cross-sectional international multicenter study |
Q38137916 | Task force report: scales for screening and evaluating tremor: critique and recommendations |
Q95273359 | Telemedicine in the era of COVID-19: a neurosurgical perspective |
Q48702809 | Teneurin transmembrane protein 4 is not a cause for essential tremor in a Canadian population. |
Q42333459 | Thalamotomy for essential tremor: FDA approval brings brain treatment with FUS to the clinic |
Q64882782 | The Burden of Movement Disorders in Cameroon: A Rural and Urban-Based Inpatient/Outpatient Study. |
Q38979621 | The Effect of Uni- and Bilateral Thalamic Deep Brain Stimulation on Speech in Patients With Essential Tremor: Acoustics and Intelligibility. |
Q36603348 | The NEDICES Study: Recent Advances in the Understanding of the Epidemiology of Essential Tremor |
Q41669408 | The Olivary Hypothesis of Essential Tremor: Time to Lay this Model to Rest? |
Q27010102 | The differential diagnosis and treatment of tremor |
Q47844844 | The effects of Thalamic Deep Brain Stimulation on speech dynamics in patients with Essential Tremor: An articulographic study |
Q36944876 | The inferior olivary nucleus: a postmortem study of essential tremor cases versus controls |
Q33754056 | The microtubule associated protein tau H1 haplotype and risk of essential tremor |
Q40847107 | The phase difference between neural drives to antagonist muscles in essential tremor is associated with the relative strength of supraspinal and afferent input |
Q55289143 | The potential value of probabilistic tractography-based for MR-guided focused ultrasound thalamotomy for essential tremor. |
Q45961563 | The safety and efficacy of thalamic deep brain stimulation in essential tremor: 10 years and beyond. |
Q37196752 | The top 100 cited articles in essential tremor |
Q27022935 | The treatment of tremor |
Q47138596 | Therapeutic Stroke - an Interesting Case of Ischemic Stroke in Bilateral Thalamic and Subthalamic Regions Resulting in Reduction of Essential Tremor |
Q24201606 | Topiramate for essential tremor |
Q38836991 | Topiramate for essential tremor. |
Q46830874 | Torpedoes in the cerebellar vermis in essential tremor cases vs. controls |
Q88582650 | Tracking the central and peripheral origin of tremor |
Q90599363 | Transient, Isolated Head Tremor in "Unaffected" Individuals: Is Essential Tremor an Even More Prevalent Disease Than We Suppose? |
Q33773385 | Treatment of Movement Disorders With Focused Ultrasound |
Q34025450 | Treatment of patients with essential tremor |
Q92628290 | Treatment with Botulinum Neurotoxin Improves Activities of Daily Living and Quality of Life in Patients with Upper Limb Tremor |
Q40337551 | Tremble and tremor: Etymology, usage patterns, and sound symbolism in the history of English |
Q92189852 | Tremor Control Devices for Essential Tremor: A Systematic Literature Review |
Q44166555 | Tremor in inflammatory neuropathies |
Q35268078 | Tremor in school-aged children: a cross-sectional study of tremor in 819 boys and girls in Burgos, Spain |
Q36656153 | Tremor in the elderly: Essential and aging-related tremor |
Q50265681 | Tremor--some controversial aspects. |
Q38237310 | Twelve clinical pearls to help distinguish essential tremor from other tremors |
Q38739505 | Ultrasound treatment of neurological diseases--current and emerging applications |
Q51738798 | Unaffected first-degree relatives of essential tremor cases have more imbalance than age-matched control subjects. |
Q33759639 | Understanding essential tremor: progress on the biological front |
Q30900972 | Utility of the hand-drawn spiral as a tool in clinical-epidemiological research on essential tremor: data from four essential tremor cohorts |
Q58585143 | Ventral Intermediate Nucleus Versus Zona Incerta Region Deep Brain Stimulation in Essential Tremor |
Q99551175 | Voxel-based morphometry and task functional magnetic resonance imaging in essential tremor: evidence for a disrupted brain network |
Q60305377 | What Predicts Mortality in Essential Tremor? A Prospective, Longitudinal Study of Elders |
Q26827505 | What is essential tremor? |
Q36603099 | White matter hyperintensity burden on magnetic resonance imaging in essential tremor |
Q57968457 | White matter measures correlate with essential tremor severity-A pilot diffusion tensor imaging study |
Q92564192 | Whole genome sequencing and rare variant analysis in essential tremor families |
Q44138502 | Wine drinking and essential tremor: a possible protective role |
Q37335308 | Worse and Worse and Worse: Essential Tremor Patients' Longitudinal Perspectives on Their Condition |
Q24201497 | Zonisamide for essential tremor |
Q38610647 | Zonisamide for essential tremor. |
Q50239606 | [Essential tremor in endemic disease control agents exposed to pesticides: a case-control study]. |
Q50194661 | [Essential tremor: state of the art]. |
Q50240011 | [Genetic risk variants in Parkinson's disease and other movement disorders]. |
Q50194668 | [Pathophysiology of tremor]. |
Q93063055 | β-adrenoreceptors and the risk of Parkinson's disease |
Search more.